932 J ournal of Natural Products, 2000, Vol. 63, No. 7
Zhang et al.
E xt r a ct ion a n d Isola t ion . Ground, dried needles of T.
canadensis (4.7 kg) were extracted and treated as described
previously11 to yield 119 g of a dark brown residue. This extract
was separated using dry-column chromatography on Si gel (Si
gel 60, 70-230 mesh, Selecto Science, Norcross, GA, 1.5 kg, 8
× 83 cm) eluted with CH2Cl2-i-PrOH (9:1, 3.5 L). After elution,
the Si gel was cut into 19 equal bands, and each band was
individually eluted with EtOAc-MeOH (1:1, 600 mL). The
eluents of the columns from bands 5 through 8 were combined
and evaporated to yield 38 g of residue A, which was then
subjected to Si gel column chromatography (840 g, 9.5 × 22
cm) with hexane (1 L), hexane-CH2Cl2 (3:1 and 1:1, each 2
L), CH2Cl2 (2 L), CH2Cl2-EtOAc (4:1, 3:2, 2:3, and 1:4, each 2
L), EtOAc (2 L), and EtOAc-MeOH [4:1 (2 L), 3:2 (4 L)], to
yield fractions B (7.0-8.2 L), C (9.0-10.0 L), and D (10.0-
11.2 L).
Fraction B (4.1 g) was applied to a Si gel column (140 g, 3.5
× 39 cm), eluted with hexane (200 mL), hexane-EtOAc (9:1,
8:2, 7:3, 6:4, 1:1, 4:6, 3:7, 2:8, and 1:9, each 200 mL), EtOAc
(200 mL), and EtOAc-MeOH (9:1, 200 mL), to yield fractions
B1 (1440-1520 mL, 353 mg) and B2 (1660-1820 mL, 81 mg).
B1 was further purified by preparative HPLC to afford
2-deacetyl-taxinine J 25 (6.2 mg). Similarly, purification of B2
by preparative HPLC was followed by preparative TLC
(CH2Cl2-MeOH, 95:5) to give 1 (1.1 mg).
(3H, s, OAc), 2.13 (4H, m, H-14b and OAc), 1.90 (3H, s, H-18),
1.66 (3H, s, H-19), 1.17 (3H, s, H-16), 1.13 (3H, s, H-17); 13C
NMR (CDCl3) δ 207.4 (C-9), 171.7 (OCOCH3), 169.8 (C-2′ and
OCOCH3), 169.1 (OCOCH3), 167.8 (C-1′), 167.3 (OCOPh), 167.0
(C-5′), 140.2 (C-12), 138.0-128.0 (3′-Ph, not assigned), 133.7
(OBz-p), 132.9 (C-11), 132.4 (5′-Ph-p), 130.3 (OBz-o), 129.5
(OBz-1), 129.1 (OBz-m and 5′-Ph-m), 127.4 (5′-Ph-o), 83.0 (C-
5), 82.1 (C-4), 79.1 (C-1), 78.0 (C-10), 77.9 (C-20), 75.7 (C-7),
75.6 (C-2), 74.0 (C-2′), 71.8 (C-13), 57.6 (C-8), 52.9 (C-3′), 42.5
(C-15), 40.6 (C-3), 35.8 (C-14), 35.2 (C-6), 25.9 (C-16), 22.5
(OCOCH3), 21.3 (C-17), 20.9, 20.7 (both OCOCH3), 16.2 (C-
19), 14.6 (C-18); HMBC correlations H-2/C-1, -3, -8, and OBz;
OH-7/C-6 and -7; H-10/C-9, -11, -12, -15, and OAc; H-16/C-1,
-11, -15, and -17; H-17/C-1, -11, -15, and -16; H-18/C-11, -12,
and -13; H-19/C-3, -7, -8, and -9; H-20/C-3 and -4; H-2′/C-1′
and OAc; H-3′/C-5′; H-4′/C-5′; NOESY correlations H-2/H-20,
-17, and -19; H-3/H-6a, OH-7, -10, -14a, and -18; H-5/H-6a,
-6b, OH-7 and -20; H-6a/H-3, -5, and OH-7; H-6b/H-5 and -7;
OH-7/H-3, -5, -6a, -6b, -7, -10, and -18; H-10/H-3, OH-7, and
-18; H-13/H-14b, -16 and -18; H-16/H-13; H-17/H-2; H-18/H-
3, OH-7, -10, -13, and -2′; H-19/H-2, -7, and -20; H-20/H-2, -5,
and -19; H-2′/H-18, -3′, and OAc; H-3′/H-2′, -4′, and OAc; H-4′/
H-3′; HRFABMS m/z 918.33123 (calcd for C49H53NO15Na,
918.33129); HPLC, tR ) 43.12 min; visualized as a black spot
on TLC plate with Rf ) 0.70 (CH2Cl2-Me2CO, 8:2).
Acetyla tion of 7-epi-ta xol. 7-epi-Taxol7 (6 mg) was treated
with 0.5 mL of acetic anhydride and 0.5 mL of pyridine at room
temperature for 24 h and yielded a major product identical to
3: [R]21D -27° (c 0.34, CHCl3); (NMR, HRFABMS, HPLC, and
TLC).
Fraction C (5.7 g) was applied to a Si gel column (126 g, 4.5
× 21 cm) and eluted with hexane-CH2Cl2 [1:1 (300 mL), 4:6,
3:7, 2:8, and 1:9, each 200 mL], CH2Cl2 (200 mL), CH2Cl2-
EtOAc (9:1, 8:2, 7:3, 6:4, 1:1, 4:6, 3:7, and 2:8, each 200 mL),
EtOAc (200 mL), and EtOAc-MeOH (8:2, 400 mL) to afford
fraction C1 (2480-3060 mL). Fraction C1 (449.5 mg) was
further purified by preparative HPLC, followed by preparative
TLC (CH2Cl2-Me2CO, 8:2 and hexane-n-BuOH, 8:2) and
semipreparative HPLC, to finally yield 1â,7â-dihydroxy-4â,20-
epoxy-2R,5R,9R,10â,13R-pentaacetoxytax-11-ene27 and 1â,9R-
dihydroxy-4â,20-epoxy-2R,5R,7â,10â,13R-pentaacetoxytax-11-
ene27 as a mixture (1.4 mg) and 1â-hydroxy-10-deacetyl-
baccatin I28 (0.5 mg).
9-Dea cetyl-ta xin in e E (4): [R]23D +85° (c 0.11, CHCl3); 1H
NMR (CDCl3) δ (1H, d, J ) 16.0 Hz, CHdâ OCinn) 7.49 (2H,
m, Ph-m OCinn), 7.40 (3H, m, Ph-m, p-OCinn), 6.67 (1H, d, J
) 16.0 Hz, CHdR OCinn), 5.86 (1H, d, J ) 9.7 Hz, H-10), 5.78
(1H, br t, J ) 8.0 Hz, H-13), 5.47 (1H, t, J ) 3.0 Hz, H-5), 5.42
(1H, dd, J ) 6.0, 1.9 Hz, H-2), 5.38, 5.01 (each 1H, s, H-20a
and 20b), 4.34 (1H, dd, J ) 9.7, 2.4 Hz, H-9), 3.34 (1H, d, J )
6.0 Hz, H-3), 2.65 (1H, m, H-14a), 2.31 (3H, s, H-18), 2.17 (1H,
o m, OH-9), 2.11 (3H, s, OCOCH3), 2.03 (3H, s, OCOCH3), 1.97
(1H, m, H-7a), 1.86 (1H, m, H-6a), 1.82 (1H, br d, J ) 8.8 Hz),
1.79 (3H, s, OCOCH3), 1.73 (1H, m, H-6b), 1.66 (1H, m, H-7b),
1.62 (1H, s, H-17), 1.47 (1H, dd, J ) 15.3, 7.6 Hz, H-14b), 1.10
(6H, s, H-16 and H-19); 13C NMR (CDCl3) δ 170.4, 170.0, 169.2
(3 × OCOCH3), 166.0 (OCinn), 145.0 (CHdâ OCinn), 136.4 (C-
12), 134.1 (Ph-1 OCinn), 134.0 (C-11), 130.4 (Ph-p OCinn),
129.1 (Ph-m OCinn), 127.9 (Ph-o OCinn), 118.7 (CHdR OCinn),
117.7 (C-20), 78.8 (C-5), 75.8 (C-9), 75.6 (C-10), 72.2 (C-2), 70.2
(C-13), 47.9 (C-1), 44.2 (C-8), 43.7 (C-3), 37.3 (C-15), 31.4 (C-
16), 28.7 (C-6), 28.4 (C-14), 27.1 (C-17), 25.7 (C-7), 21.5, 21.4,
21.0 (3 × OCOCH3), 15.2 (C-19), 18.2 (C-19); HMBC correla-
tions H-3/C-2, -8, and -19; H-9/C-7, -8, -10, and -19; H-10/C-9,
-11, -12, -15, and OAc; H-14a/C-2, -12, and -13; H-16/C-1, -11,
-15, and -17; H-17/C-1, -11, -15, and -16; H-18/C-11, -12, and
-13; H-19/C-3, -7, -8, and -9; NOESY correlations H-1/H-2, -14a,
-16, and -17; H-2/H-1, -9, -17, and -19; H-3/H-7b, -14b, and
-18; H-5/H-6a, -6b, and -20a; H-6a/H-5 and -6b; H-6b/H-5, -6a,
and -19; H-7a/H-7b and -19; H-7b/H-3, -7a, -10, and -18; H-9/
H-2, -17, and -19; H-10/H-7b and -18; H-13/H-14a and -16;
H-14a/H-1, -13, -14b, and -16; H-14b/H-3 and -14a; H-16/H-1,
-13, -14a, and -17; H-17/H-2, -9, -16, and -19; H-18/H-3, -7,
-10, -13, and CHdR; H-19/H-2, -6b, -7a, -9, -17, and -20b;
H-20a/H-20b; H-20b/H-20a; HRFABMS m/z 631.28824 (calcd
for C35H44O9Na, 631.28830); HPLC, tR ) 47.27 min; visualized
as a black spot on TLC plate with Rf ) 0.60 (CH2Cl2-Me2CO,
8:2).
Fraction D (5.6 g) was applied to a Si gel column (125 g, 4.5
× 20 cm) and eluted with CH2Cl2 (200 mL), CH2Cl2-EtOAc
(9:1, 8:2, 7:3, 6:4, 1:1, 4:6, 3:7, 2:8, and 1:9, each 200 mL),
EtOAc (200 mL), and EtOAc-MeOH (9:1 and 8:2, each 200
mL), to obtain fractions D1 (500-700 mL), D2 (700-1000 mL),
and D3 (1740-1840 mL). Fraction D1 (130 mg) was further
purified by preparative HPLC, followed by semipreparative
HPLC, to yield 2 (2.5 mg). Fraction D2 (206 mg) was also
subjected to preparative HPLC to give 3 (1.8 mg). The other
fractions from this HPLC column were further purified by
preparative TLC (hexane-n-BuOH, 8:2, CH2Cl2-MeOH, 9:1,
and CH2Cl2-Me2CO, 8:2) to afford 4 (4.9 mg). Fraction D3 (225
mg) was purified on a preparative HPLC column, followed by
preparative TLC (EtOAc and CH2Cl2-Me2CO, 8:2), to produce
2-deacetyl-5-decinnamoyl-taxinine E26 (2.3 mg).
5-epi-Cin n a m oylca n a d en sen e (1): [R]23 +110° (c 0.01,
D
CHCl3); 1H and 13C NMR, see Table 1; HRFABMS m/z
747.29889 (calcd for C39H48O13Na, 747.29926); HPLC, tR
)
42.68 min; visualized as a brown spot on TLC plate with Rf )
0.45 (CH2Cl2-MeOH, 95:5).
2,9,10,13-Te t r a a ce t oxy-20-cin n a m oyloxy-t a xa -4(5),
11(12)-d ien e (2): [R]23 +53° (c 0.06, CHCl3); 1H and 13C
D
NMR, see Table 2; HRFABMS m/z 673.29904 (calcd for
C
37H46O10Na, 673.29887); HPLC, tR ) 53.82 min; visualized
as a black spot on TLC plate with Rf ) 0.85 (CH2Cl2-MeOH,
95:5).
1
2′-Acetyl-7-epi-ta xol (3): [R]22 -30° (c 0.05, CHCl3); H
D
NMR (CDCl3) δ 8.16 (2H, d, J ) 7.8 Hz, OBz-o), 7.72 (2H, d,
J ) 7.7 Hz, 5′-Ph-o), 7.60 (1H, t, J ) 7.4 Hz, OBz-p), 7.52 (2H,
t, J ) 7.2 Hz, OBz-m), 7.49-7.30 (8H, m, 3′-Ph and 5′-Ph-m,
p), 6.87 (1H, d, J ) 9.1 Hz, H-4′), 6.82 (1H, s, H-10), 6.22 (1H,
t, J ) 9.0 Hz, H-13), 5.97 (1H, dd, J ) 9.1, 3.3 Hz, H-3′), 5.74
(1H, d, J ) 7.1 Hz, H-2), 5.55 (1H, d, J ) 3.3 Hz, H-2′), 4.93
(1H, dd, J ) 8.6, 3.4 Hz, H-5), 4.67 (1H, d, J ) 11.4 Hz, 7-OH),
4.38 (2H, br s, H-20a and b), 3.93 (1H, d, J ) 7.1 Hz, H-3),
3.70 (1H, br ddd, J ) 11.4, 4.7, 1.7 Hz, H-7), 2.53 (3H, s, OAc),
2.36 (1H, m, H-14a), 2.33, 2.28 (each, 1H, m, H-6a and b), 2.18
Acet yla t ion of 4. Compound 4 (2 mg) was treated with
acetic anhydride (0.5 mL) in pyridine (0.5 mL) at room
temperature for 22 h, and the product was determined by [R]21
D
+47° (c 0.12, CHCl3), 1H NMR, and HPLC data to be identical
to taxinine E.11,16
2-Dea cetyl-ta xin in e J : [R]23 +17° (c 0.15, CHCl3);25
D
HRFABMS m/z 689.29406 (calcd for C37H46O11Na, 689.29378);
HPLC, tR ) 43.89 min; visualized as a black spot on TLC plate
with Rf ) 0.75 (CH2Cl2-Me2CO, 8:2).